Sanginita Chemicals Q3 FY26: Net Loss Widens to ₹2.78 Crore
Sanginita Chemicals reported a net loss of ₹2.78 Crore for the quarter ended December 31, 2025. This is a widening of the loss from ₹0.68 Crore in the previous quarter and a reversal from a profit of ₹0.14 Crore in the same quarter last year. Total income for the quarter was ₹43.47 Crore.
The widening net loss and decreased total income are material financial developments that could impact investor sentiment and the company's stock performance.
The company reported a significant increase in net loss for the quarter compared to both the previous quarter and the same quarter last year, indicating a negative financial performance.
Sanginita Chemicals Limited announced its unaudited financial results for the quarter ended December 31, 2025. The company's Board of Directors took on record these results during a meeting held on January 10, 2026, which commenced at 3:00 p.m. and concluded at 4:00 p.m.
The company reported a total income of ₹4347.81 Lakhs for the quarter, a slight decrease from ₹4410.87 Lakhs in the previous quarter (September 30, 2025) and significantly lower than ₹6162.24 Lakhs in the same quarter last year (December 31, 2024).
Total expenses for the quarter amounted to ₹4627.11 Lakhs. The company incurred a loss before tax of ₹279.30 Lakhs for the quarter ended December 31, 2025, compared to a loss of ₹69.02 Lakhs in the previous quarter and a profit of ₹18.82 Lakhs in the corresponding quarter of the previous year.
After accounting for taxes and other comprehensive income, the net loss for the quarter widened to ₹278.24 Lakhs (approximately ₹2.78 Crore). This compares to a net loss of ₹67.75 Lakhs in the previous quarter and a net profit of ₹14.08 Lakhs in the same quarter last year.
Basic and diluted earnings per share (EPS) for the quarter stood at ₹(1.07), compared to ₹(0.26) in the previous quarter and ₹0.05 in the corresponding quarter of the prior year.
The company also confirmed that there has been no deviation or variation in the utilization of issue proceeds, as per SEBI regulations.
What to do with a filing like this
Sanginita Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sanginita Chemicals Limited. Read the original for the full detail.